MedTrace Logo

Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury

NCT03319966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92

Last updated 2020-10-19

No results posted yet for this study

Summary

The purpose of this single center, longitudinal, pilot study is to provide evidence for the use of an eye tracking system as an objective tool to identify mild traumatic brain injury (mTBI) related oculomotor dysfunction (OMD) and predict the effectiveness of neurovision rehabilitation (NVR) of OMD. Eye tracking visual stimulus measurements will be compared to objective developmental optometrist (OD) diagnosis and assessments. It will be determined whether an eye tracking system can predict the presence or absence of mTBI related OMD and whether mTBI patients who have OMD based on the eye tracking system will respond positively to NVR.

Conditions

  • Mild Traumatic Brain Injury
  • Brain Concussion
  • Convergence Insufficiency
  • Accommodative Insufficiency
  • Saccadic Eye Movement Deficiency
  • Oculomotor Dysfunction

Sponsors & Collaborators

  • Hennepin Healthcare Research Institute

    lead OTHER

Principal Investigators

  • Sarah Rockswold, MD · Hennepin County Medical Center, Minneapolis

Eligibility

Min Age
13 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-18
Primary Completion
2020-08-21
Completion
2020-08-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03319966 on ClinicalTrials.gov